Mini Medical School: A 20/20 View of Cancer
Mini Medical School offers a unique perspective into the health sciences at the University of Minnesota. Once a week for six weeks, students – ranging in age from high school students to retirees – with a shared interest in health embark on a journey examining the scientific foundations of health and disease. Presented using common language for ease of understanding complex topics, your guides are internationally renowned University of Minnesota experts who are shaping the way health care is delivered locally and globally.
In addition to learning from our world-renowned faculty in the classroom, students have the opportunity to get supplemental information relevant to the session topic from exhibitors. A 20/20 View of Cancer is designed to give students insight into research centric key cancer concepts and on cancer in Minnesota.
Cancer in Minnesota
Rebekah Pratt, PhD
Program in Health Disparities Research, and Department of Family Medicine and Community Health
- Cancer disparities particularly impact Somali immigrants in Minnesota.
- There are a wide range of reasons for this, including social, cultural and religious influences.
- There are also great opportunities to address these disparities through conducting community partnered research in collaboration with the Somali community.
- We can also address these disparities by partnering with local clinics and health care providers.
- Family based and strengths focused approaches, including incorporating messages from the Muslim faith in cancer prevention efforts, can make a positive difference on cancer disparities for Somali community members.
Clinical Trials and the Minnesota Clinical Cancer Trials Network
Doug Yee, MD
Director, Masonic Cancer Center
John H. Kersey Chair in Breast Cancer Research
Departments of Medicine and Pharmacology
- Population and laboratory studies identify potential new treatment strategies.
- Clinical trials are necessary to develop new drugs and improve cancer outcomes.
- Partnering with patients to enroll in clinical trials is necessary to defeat cancer.
- Reducing disparities in cancer outcomes requires new strategies to include patients who do not live in metropolitan areas.